Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
申请人:Nogra Pharma Limited
公开号:US20150265563A1
公开(公告)日:2015-09-24
The present invention relates to compounds comprising the general formula (I), in which R
1
and R
2
, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR
3
, —CH(OR
3
)COOH, in which R
3
is selected from H, phenyl, benzyl, —CF
3
or —CF
2
CF
3
, vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
本发明涉及通式(I)的化合物,其中R1和R2可以相同或不同,选自包括-H或具有1至6个碳原子的线性或支链烷基或共同形成具有5或6个原子的芳香或脂肪环的群;Y和Z可以相同或不同,选自包括-H,-OH,-COOH,-OR3,-CH(OR3)COOH的群,其中R3选自H,苯基,苄基,-CF3或-CF2CF3,乙烯基,丙烯基和具有1至6个碳原子的线性或支链烷基。